Topical BioMedics Inc. is building on its Topricin topical pain relief brand with MyPainAway powered by Topricin, a product line extension. The company said products in the new line address specific ailments and pain issues.
Jim Holbrook has been appointed as chief executive officer at Daymon Worldwide, succeeding Carla Cooper, who is retiring. The consumables retail marketing firm said Thursday that Holbrook is slated to take the helm as CEO on Sept. 1. He also will join Daymon’s board of directors.
AmerisourceBergen Corp. has launched the AmerisourceBergen Foundation, a nonprofit charitable organization that provides grants to health- and pharmaceutical-related causes and educational opportunities.
Aurobindo Pharma Ltd. has gained Food and Drug Administration approval for alprazolam tablets, a medication for anxiety. Aurobindo said its alprazolam product — available in dosages of 0.25 mg, 0.5 mg, 1 mg and 2 mg — is a generic version of Xanax tablets from Pfizer Inc. Part of a group of
Hershey Co. is expanding its Brookside wholesome snack brand with the addition of Brookside Fruit & Nut Bars. Hershey said Tuesday that the new offering builds on the success of Brookside Dark Chocolates.
DenTek has gone live with a new branded website featuring full e-commerce capabilities. The oral care brand said Monday that DenTek.com now provides oral care product information and tips plus the ability for consumers to buy items directly through the site.
Pfizer Inc. has entered into an agreement with Synthon to acquire the exclusive U.S. commercialization rights for glatiramer acetate, a potential generic version of Teva Pharmaceuticals’ Copaxone for the treatment of relapsing remitting multiple sclerosis (RRMS).
Hikma Pharmaceuticals PLC, a fast growing multinational pharmaceutical group, plans to acquire Roxane Laboratories from Boehringer Ingelheim in a deal valued at $2.65 billion. Hikma said the agreement stands to transform its position in the U.S.
Par Pharmaceutical Companies Inc. has released an authorized generic version of Par Specialty Pharmaceutical’s Megace ES oral suspension.
Unilever and Walgreens have partnered with Me to We to provide customers with a way to make a positive impact on the world through everyday purchases.
Troy Healthcare is expanding retail distribution of its Stopain Migraine topical pain reliever, which a recent study found to be safe and effective in treating an acute migraine attack.
David Taylor, Procter & Gamble Co.’s group president of global beauty, grooming and health care, has been chosen to succeed A.G. Lafley as the company’s president and chief executive officer. P&G said late Tuesday that Taylor is slated to take the helm as CEO on Nov.
A new sonic toothbrush from Brush Buddies brings consumers a “fresh-out-of-the-dentist clean feeling at drug store prices,” the company said.
Sandoz has launched budesonide inhalation suspension, an asthma medication, in the U.S. market. The Novartis subsidiary said Tuesday that it will market its budesonide inhalation suspension in 1-mg strength, and it expects 180-day generic drug marketing exclusivity for that dosage.
Teva Pharmaceutical Industries Ltd. plans to buy Allergan’s generic drug business for about $40.5 billion and, with the deal, has withdrawn its proposal to acquire Mylan N.V. for approximately $40 billion. Teva said Monday that Dublin, Ireland-based Allergan will receive $33.
Performance Health LLC has expanded its roster of topical analgesic, rehabilitation and wellness products with Perform Atomic Heat, a new topical formula for warming the body before physical activity and relieving muscle, joint and arthritis pain.
